Application of xylan derivative as hydrophilic sustained-release material in preparation of drug sustained-release tablet
A technology of slow-release materials and derivatives, applied in drug delivery, pharmaceutical formulations, organic active ingredients, etc., can solve the problems that cannot be directly applied, and achieve the effect of large drug loading, large adjustment range, and wide adaptability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0034] In this example, xylan derivatives are used to prepare acidic water-soluble drugs—diclofenac sodium sustained-release tablets.
[0035] The first situation: the diclofenac sodium sustained-release tablet is made of the following raw materials in mass percentage: diclofenac sodium 40%, carboxymethyl xylan 51.4% and ethyl cellulose 8.6% (i.e. carboxymethyl xylan and ethyl cellulose The mass ratio of base cellulose is 6:1).
[0036] The second kind of situation: this diclofenac sodium sustained-release tablet is made of the raw material of following mass percentage: diclofenac sodium 40%, carboxymethyl xylan 48% and ethyl cellulose 12% (being carboxymethyl xylan and ethyl cellulose The mass ratio of base cellulose is 4:1).
[0037] The third kind of situation: this diclofenac sodium sustained-release tablet is made of the raw material of following mass percentage: diclofenac sodium 40%, carboxymethyl xylan 30% and ethyl cellulose 30% (being carboxymethyl xylan and ethyl c...
Embodiment 2
[0045] In this example, xylan derivatives are used to prepare a neutral water-soluble drug—guaifenesin sustained-release tablets. The guaifenesin sustained-release tablet is made of the following raw materials in mass percentage: 30% of guaifenesin, 41% of carboxymethyl xylan, 21% of ethyl cellulose and 8% of hydroxypropyl methyl cellulose. The above four raw materials were pulverized through a 100-mesh sieve, fully stirred and mixed evenly, sprayed with 75% volume concentration of ethanol, granulated through a 16-mesh sieve, and dried at 50° C. for 2 hours. Add magnesium stearate of 1% of the total mass of the granules to the dried granules as a lubricant, mix well, and send the granules into a tablet machine for tableting to obtain guaifenesin sustained-release tablets.
[0046] The release profile of guaifenesin extended-release tablets, such as Figure 4 shown.
Embodiment 3
[0048] In this example, xylan derivatives are used to prepare alkaline water-soluble drugs—theophylline sustained-release tablets. The theophylline sustained-release tablet is made of the following raw materials in mass percentage: 25% of theophylline, 23% of hydroxypropyl xylan, 42% of ethyl cellulose and 10% of carboxymethyl cellulose. The above four raw materials were pulverized through a 100-mesh sieve, fully stirred and mixed evenly, sprayed with 75% volume concentration of ethanol, granulated through a 16-mesh sieve, and dried at 50° C. for 2 hours. Add magnesium stearate of 1% of the total mass of the granules to the dried granules as a lubricant, mix well, and send the granules into a tablet machine for compression to obtain theophylline sustained-release tablets.
[0049] The release profile of theophylline sustained-release tablets, such as Figure 5 shown.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com